Synonyms

Intertriginous inflammation

Intravascular lymphomatosis 311

Interferon-a. Dermatologic indications and dosage

Disease

Adult dosage

Child dosage

AIDS-associated

BG million IU/m2 subcutaneously or

Not applicable

Kaposi's sarcoma

intramuscularly B times weekly

Basal cell carcinoma 500,000 IU subcutaneously 3 times Not applicable weekly for 3 weeks

Basal cell carcinoma 500,000 IU subcutaneously 3 times Not applicable weekly for 3 weeks

Behcet's disease 2 million IU subcutaneously weekly, Not indicated escalating to 12 million IU over 2 months

Cutaneous T cell 1 million IU intralesional weekly for Not indicated lymphoma 4 weeks

Cutaneous T cell 1 million IU intralesional weekly for Not indicated lymphoma 4 weeks

Genital warts

250,000 IU intralesional twice weekly for 8 weeks

Not indicated

Giant condyloma of Buschke and Lowenstein

250,000 IU intralesional twice weekly for 8 weeks

Not applicable

High risk melanoma adjuvant therapy

20 million IU per m2 IV 5 days weekly for 4 weeks, followed by 10 million IU per m2 subcutaneously 3 times weekly for 48 weeks

20 million IU per m2 IV 5 days weekly for 4 weeks, followed by 10 million IU per m2 subcutaneously 3 times weekly for 48 weeks

Infantile hemangioma

Not applicable

3 million IU subcutaneously daily for up to 18 months

Keloid, post-excision

1.5 million IU intralesional twice over 4 days

1.5 million IU intralesional twice over 4 days

Squamous cell carcinoma

500,000 IU subcutaneously 3 times weekly for 3 weeks

Not applicable

0 0

Post a comment